Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.

Marth, C

Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells. [electronic resource] - British journal of cancer 1997 - 1328-32 p. digital

Publication Type: Journal Article

0007-0920

10.1038/bjc.1997.556 doi


Antineoplastic Agents--pharmacology
Cisplatin--pharmacology
Drug Resistance, Neoplasm
Female
Genes, erbB-2
HLA-DR Antigens--analysis
Humans
Interferon-gamma--pharmacology
Ovarian Neoplasms--drug therapy
Tumor Cells, Cultured